Targeted Sequencing Reveals Low-Frequency Variants in <i>EPHA</i> Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy
María Apellániz-Ruiz(Navarrabiomed), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), María Currás-Freixes(Spanish National Cancer Research Centre), Maria J. Merino(National Institutes of Health), Fátima Al‐Shahrour(Broad Institute), María Sereno(Hospital Universitario Infanta Sofía), Lara M. Munín Sánchez(Spanish National Cancer Research Centre), Henrik Gréen(Linköping University), Nuria Romero-Laorden(Spanish Oncology Genitourinary Group), Héctor Tejero(Spanish National Cancer Research Centre), Isabel Calvo(Centro Oncológico de Galicia), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Elisabeth Åvall‐Lundqvist(Karolinska University Hospital), Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Andrés Redondo(Hospital Universitario La Paz), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Alberto Cascón(Spanish National Cancer Research Centre), Gerardo Gutiérrez‐Gutiérrez(Erasmus University Rotterdam), Beatriz Castelo, Jesús García-Donás(Universidad San Pablo CEU)
Cited by 22
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Comprehensive molecular characterization of mitochondrial genomes in human cancers
|Nature Genetics|2020|520